文献速递心力衰竭与心肌病血脂与心血管预防

γ-谷氨酰转移酶变异性与心力衰竭住院风险

Gamma-glutamyl transferase variability and the risk of hospitalisation for heart failure.
PubMed 文献 · Heart · 2020-04-17

随访8.4年间1387例(1.16%)发生HHF。多变量调整后,GGT变异性最高四分位组(CV)相比最低组的HHF风险HR为1.22(95%CI 1.05-1.42),SD和VIM结果一致。

要点

  • GGT变异性最高四分位组(CV)的HHF风险是最低组的1.22倍(95%CI 1.05-1.42)。
  • 用SD和VIM评估GGT变异性得到一致结果,HR分别为1.37和1.29。
  • GGT变异性与HHF的关联在血脂异常个体中更突出。

核心结论

  • GGT变异性与心衰住院发生率独立相关,较高GGT变异性可能作为未来心衰风险的指标。

研究设计与样本

  • GGT变异性以变异系数(CV)、标准差(SD)和均值独立变异性(VIM)计算。

主要发现

  • 随访8.4年间1387例(1.16%)发生HHF。
  • 多变量调整(包括酒精摄入和平均GGT水平)后,GGT变异性(CV)最高四分位组相比最低组的HHF风险HR为1.22(95%CI 1.05-1.42)。
  • SD评估的GGT变异性HR为1.37(95%CI 1.16-1.62),VIM评估的HR为1.29(95%CI 1.11-1.50)。
  • 亚组分析显示关联在血脂异常个体中更突出。

临床怎么用

  • GGT变异性可能作为未来心衰风险的辅助 indicator,尤其对血脂异常人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gamma-glutamyl transferase (GGT) is associated with oxidative stress, inflammation, cardiovascular disease and mortality. Variability in metabolic parameters has recently emerged as an indicator of adverse health outcomes, including heart failure (HF). METHODS: We investigated whether GGT variability was associated with the incidence of hospitalisation for heart failure (HHF) in a Korean population without previous HF, ischaemic heart disease or liver disease. This longitudinal cohort study analysed 119 201 individuals from the Korean National Health Insurance Service-National Health Screening Cohort. GGT variability was calculated as the coefficient of variation (CV), SD and variability independent of the mean (VIM). RESULTS: During the 8.4 years of follow-up, 1387 cases of HHF (1.16%) developed. In the multivariable-adjusted model, the HR of HHF was 1.22 (95% CI 1.05 to 1.42) in the highest quartile of GGT variability compared with the lowest quartile, as assessed by CV after adjusting for confounding factors, including alcohol consumption and mean GGT levels. Consistent results were obtained using other indices of GGT variability such as SD (HR 1.37, 95% CI 1.16 to 1.62) and VIM (HR 1.29, 95% CI 1.11 to 1.50). In a subgroup analysis stratified by risk factor variables, although a similar relationship was observed, it was more prominent in individuals with dyslipidaemia. CONCLUSIONS: The results of the present study demonstrated that variability in GGT was independently associated with the incidence of HHF. These findings suggest that higher GGT variability may be useful as an indicator of future risk of HF.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Hong SH, Lee JS, Kim JA, et al. Gamma-glutamyl transferase variability and the risk of hospitalisation for heart failure. Heart. 2020. PMID: 32303630. doi:10.1136/heartjnl-2019-316271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。